UBS AM’s Mobix Labs MOBX Stock Holding History

UBS AM’s Portfolio MOBX Stock Details MOBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90	Closed	-$300	–	3820
2026 Q1	$300	Hold	90	–	–	﹤0.01%	3755
2025 Q4	$240	Buy	+90	New	+$563	﹤0.01%	3267

Other funds holding MOBX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Capital Wealth Advisors Denver, Colorado $148M AUM 91.21% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Corient Private Wealth Miami, Florida $77.5B AUM 27.94% 1-Year Est. Return

ACM

Alessandra Capital Management Torrance, California $141M AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS AM's MOBX Position: Q2 2026 in Review

UBS AM sold out of Mobix Labs (MOBX) in Q2 2026, closing a stake of 90 shares — an estimated $300 sold.

UBS AM first reported a position in MOBX in Q4 2025 and held it in 2 quarters. The position peaked at $300 in Q1 2026. 25 funds tracked by Wall St. Rank hold MOBX as of Q2 2026.

UBS AM reported no remaining Mobix Labs position as of Q2 2026 after selling out during the quarter.
UBS AM sold 90 Mobix Labs shares in Q2 2026, an estimated $300.
UBS AM first reported a position in Mobix Labs in Q4 2025 and held it in 2 quarters.
UBS AM's Mobix Labs position peaked at $300 in Q1 2026.
25 funds tracked by Wall St. Rank held Mobix Labs as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.